Skip to main content
OpenTrials

Clinical trial condition

Cholestasis, progressive familial intrahepatic 1

Explore clinical trials studying Cholestasis, progressive familial intrahepatic 1. Study availability and eligibility vary by location and protocol.

24 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Cholestasis, progressive familial intrahepatic 1 trial results

Recruiting

Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers

NCT06777914

Conditions
Cholestasis, progressive familial intrahepatic 1, Cholestatic Liver Disease, Hepatobiliary Cancers, +1 more
Locations
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna - Programma Chirurgia addominale nell'insufficienza d'organo terminale e nei pazienti con trapianto d'organo Bologna, Italy
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna - UO Chirurgia Epatobiliare e dei Trapianti Bologna, Italy
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna - UO Gastroenterologia Bologna, Italy
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna - UO Medicina Interna per il trattamento delle gravi insufficienze d'organo Bologna, Italy
View Trial Details
Completed

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

NCT03659916

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +3 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado Denver, Colorado, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Riley Hospital for Children - Riley Children's Specialists Indianapolis, Indiana, United States
View all 41 locations
View Trial Details
Completed

A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in Spain

NCT07191704

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +3 more
Locations
  • H. Clinic (first CEIm) Barcelona, Spain
  • H. Vall Hebron Barcelona, Spain
  • H. Reina Sofía Córdoba, Spain
  • H. Dr. Negrín Las Palmas, Spain
View Trial Details
Completed

An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)

NCT04185363

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +4 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Advent Health Orlando, Florida, United States
  • Children's Hospital at Montefiore The Bronx, New York, United States
View all 28 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).

NCT04729751

Conditions
Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +14 more
Locations
  • Children Hospital LA Los Angeles, California, United States
  • University of California - San Francisco San Francisco, California, United States
  • Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Ochsner Hospital for Children New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Completed

A Study of TAK-625 for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)

NCT05543187

Conditions
Cholestasis, progressive familial intrahepatic 1, Progressive Familial Intrahepatic Cholestasis (PFIC)
Locations
  • University of Tsukuba Hospital Tsukuba, Ibaraki, Japan
  • Yokohamashi Tobu Hospital Yokohama, Kanagawa, Japan
  • Tsuyama Chuo Hospital Tsuyama, Okayama-ken, Japan
  • Osaka University Hospital Suita, Osaka, Japan
View Trial Details
Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
View Trial Details

Related conditions